Brain zap study reveals secrets of speech learning

NCT ID NCT07455760

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how two brain areas—the subthalamic nucleus and the ventral intermediate nucleus of the thalamus—help us learn and produce speech. Researchers will temporarily turn deep brain stimulation (DBS) on or off in 80 people with Parkinson's disease or essential tremor while they practice saying new sound sequences. The goal is to understand how DBS affects speech learning, which may lead to better DBS settings that improve both movement and speech.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
deep brain stimulation (DBS) targeting the subthalamic nucleus or ventral intermediate nucleus of the thalamus
What this could lead to
If successful, this research could guide doctors in fine-tuning DBS settings to better preserve or improve speech in people with Parkinson's disease or essential tremor.
What could go wrong
This is an early-stage observational study with only 80 participants, so results may not apply to everyone. The temporary turning off of DBS may cause discomfort or temporary worsening of symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL TREMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Boston University

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.